학술논문

Heterozygosity of stromelysin-1 (rs3025058) promoter polymorphism is associated with gastric cancer.
Document Type
Journal Article
Source
Indian Journal of Cancer. Apr-Jun2015, Vol. 52 Issue 2, p251-254. 4p.
Subject
*HETEROZYGOSITY
*STROMELYSINS
*STOMACH cancer
*SINGLE nucleotide polymorphisms
*TUMOR growth
*ETIOLOGY of diseases
*GENETICS
*DISEASE susceptibility
*GENES
*GENETIC techniques
*PROTEOLYTIC enzymes
*STOMACH tumors
*GENETIC carriers
*GENOTYPES
Language
ISSN
0019-509X
Abstract
Background: Gastric cancer (GC) is the third most common cancer in India and is mediated by multiple genetic, epigenetic and environmental risk factors. A single nucleotide polymorphism rs3025058 at -1171 of the stromelysin-1 (matrix metalloproteinase [MMP]-3) promoter is resulting due to insertion/deletion of adenine thought to have an impact on increasing the risk for tumor formation.Aim: This study is aimed to understand the role of stromelysin-1 rs3025058 (-1171, 5A/6A) promoter polymorphism in the etiology of GC in Indian population.Materials and Methods: Genomic DNA was isolated from blood samples of the GC patients and controls. The genotyping of stromelysin-1 rs3025058 (-1171, 5A/6A) promoter polymorphism was carried out by amplification refractory mutation system-polymerase chain reaction method followed by agarose gel electrophoresis.Results: The frequency of 5A/5A, 5A/6A, and 6A/6A genotypes in GC patients were 7.69%, 76.92%, and 15.38%, while in controls were 5.31%, 86.73%, and 7.96%, respectively. There was a significant difference in the distribution of 5A/6A genotype in patients compared to the controls (P < 0.05).Conclusion: This study showed an increased frequency of heterozygotes for stromelysin-1 rs3025058 and thought to be involved in the etiology of GC. [ABSTRACT FROM AUTHOR]